FGF21 deletion protected mice from DSS-induced acute colitis by increasing IL-22 expression-mediated epithelial STAT3 activation, which decreased intestinal inflammation and maintained intestinal goblet cell and Paneth cell homeostasis. The gene discussed is IL22; the disease is colitis.